Recursion Pharmaceuticals Inc Cl A (RXRX)

$9.51 0.50 (5.00%)

16:15 EDT RXRX Stock Quote Delayed 30 Minutes

RXRX Stock Earnings: Recursion Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

RXRX stock results show that Recursion Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

The Top 3 Biotech Stocks to Buy in April 2024

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 4.87M

Day's Range $9.43 - $10.11

52-Week Range $4.97 - $16.75

Dividend & Yield N/A (N/A)

RXRX Stock Predictions, Articles, and Recursion Pharmaceuticals Inc Cl A News

From InvestorPlace
From the Web

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?

By Rich Duprey, InvestorPlace Contributor Mar 1, 2024

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Get Rich Quick With These 3 AI Stocks to Buy Now

By Matthew Farley, InvestorPlace Contributor Feb 18, 2024

Jump on the AI revolution with three AI stocks poised for rapid growth. Don't miss out on these potential wealth generators in the tech boom.

5 Stocks to Buy to Invest Like Nvidia

By Samuel O'Brient, InvestorPlace Reporter Feb 15, 2024

Do you want to invest like Nvidia? Here are the stocks to buy if you want to follow the chipmaker methodology and focus on AI exposure.

3 AI Stocks that Could be the Next Palantir

By Jeremy Flint, InvestorPlace Contributor Feb 15, 2024

These niche AI stocks are using Palantir's ascent as a roadmap to market dominance in their respective fields.

Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock

By Chris MacDonald, InvestorPlace Contributor Jan 9, 2024

Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.

3 Biotech Stocks at the Forefront of the Quest for Eternal Youth

By Jeremy Flint, InvestorPlace Contributor Jan 2, 2024

Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.

3 Genomics Stocks to Unlock the Future of Medicine

By Jeremy Flint, InvestorPlace Contributor Dec 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

By John Blankenhorn, InvestorPlace Contributor Dec 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

By Jeremy Flint, InvestorPlace Contributor Nov 23, 2023

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence

By Ian Cooper, InvestorPlace Contributor Nov 9, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

3 Stocks to Buy for Their Proximity to Nvidia

By Jeremy Flint, InvestorPlace Contributor Nov 8, 2023

Nvidia isn't the only AI stock on the market. These three companies stand to benefit from Nvidia's success while offering diversification.

The 7 Best Cathie Wood Stocks to Buy Now: November Edition

By Muslim Farooque, InvestorPlace Contributor Nov 1, 2023

Dive into the dynamic world of Cathie Wood stocks, wagering on the disruptive tech gems shaping tomorrow's investment landscape.

3 Extra-Speculative Stocks That Could Make You Very, Very Rich

By Jeremy Flint, InvestorPlace Contributor Oct 26, 2023

Speculative stocks are a growth investor's dream—potential for untold riches, if you can find the stocks that will survive.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor Sep 22, 2023

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

By Muslim Farooque, InvestorPlace Contributor Sep 5, 2023

These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances.

Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now

By Ian Cooper, InvestorPlace Contributor Aug 21, 2023

Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing.

3 AI Stocks You’ll Regret Not Buying Soon

By Ian Cooper, InvestorPlace Contributor Aug 8, 2023

AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.

Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?

By Bret Kenwell, InvestorPlace Contributor Jul 19, 2023

Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week.

3 Biotech Stocks Using AI to Change Healthcare Forever

By Jeremy Flint, InvestorPlace Contributor Jul 14, 2023

The past year provided a peek into the future of biotech and healthcare. Megafirms like Medtronic (NYSE:MDT) led the way, partnering with tech giants such…

Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?

By Shrey Dua, InvestorPlace Assistant News Writer Jul 13, 2023

RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment.

Recursion Pharmaceuticals Inc Cl A (RXRX)

RXRX Stock Earnings: Recursion Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024

The Top 3 Biotech Stocks to Buy in April 2024

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Recursion Pharmaceuticals Inc Cl A (RXRX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

RXRX Stock Predictions, Articles, and Recursion Pharmaceuticals Inc Cl A News

Subscriber Sign in